- Home
- RVYL vs POAI Comparison
RVYL vs POAI Comparison
Compare RVYL & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVYL
- POAI
- Stock Information
- Founded
- RVYL 2007
- POAI 2002
- Country
- RVYL United States
- POAI United States
- Employees
- RVYL N/A
- POAI N/A
- Industry
- RVYL Professional Services
- POAI Industrial Specialties
- Sector
- RVYL Consumer Discretionary
- POAI Health Care
- Exchange
- RVYL Nasdaq
- POAI Nasdaq
- Market Cap
- RVYL 7.3M
- POAI 7.8M
- IPO Year
- RVYL N/A
- POAI N/A
- Fundamental
- Price
- RVYL $0.38
- POAI $14.77
- Analyst Decision
- RVYL Hold
- POAI Hold
- Analyst Count
- RVYL 1
- POAI 1
- Target Price
- RVYL N/A
- POAI N/A
- AVG Volume (30 Days)
- RVYL 20.3M
- POAI 230.9K
- Earning Date
- RVYL 11-13-2025
- POAI 11-11-2025
- Dividend Yield
- RVYL N/A
- POAI N/A
- EPS Growth
- RVYL N/A
- POAI N/A
- EPS
- RVYL N/A
- POAI N/A
- Revenue
- RVYL $48,904,000.00
- POAI $1,664,696.00
- Revenue This Year
- RVYL $27.50
- POAI $486.27
- Revenue Next Year
- RVYL $35.71
- POAI $65.50
- P/E Ratio
- RVYL N/A
- POAI N/A
- Revenue Growth
- RVYL N/A
- POAI 71.65
- 52 Week Low
- RVYL $0.25
- POAI $8.25
- 52 Week High
- RVYL $2.35
- POAI $45.90
- Technical
- Relative Strength Index (RSI)
- RVYL 54.85
- POAI 78.34
- Support Level
- RVYL $0.38
- POAI $12.15
- Resistance Level
- RVYL $0.47
- POAI $15.15
- Average True Range (ATR)
- RVYL 0.04
- POAI 1.98
- MACD
- RVYL 0.01
- POAI 1.19
- Stochastic Oscillator
- RVYL 36.22
- POAI 45.66
About RVYL Ryvyl Inc.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.